AARP unleashes 'Rx Price Watch' report

Share this article:
AARP, which has taken heat for omitting rebates and discounts from its old “Rx Watchdog” pricing reports, said it found such discounts do little to hold down prices.

The association rebranded its latest report “Rx Price Watch” to mark a switch to retail prices, or the amount that is actually charged to consumers (and/or insurers), as the primary data source. AARP adopted the Thomson Reuters MarketScan Research Databases, which compares the rate of inflation with changes in retail price charged to consumers ages 50 and older enrolled in employer-sponsored health plans.

Even with the different methodology, findings paralleled the association's earlier “Watchdog” reports: The new report showed that prices for 217 widely used brand name drugs climbed 8.3% in 2009 (compared to manufacturer increases of 9.3%). That's higher than the rate of increase during any single year since 2004 and far greater than the inflation rate during the last five years, which has fallen 0.3%, the report noted.

PhRMA called the new report “distorted and misleading” because it didn't reflect generic drugs, which account for 75% of prescribing. But AARP said most of the drugs surveyed are still under patent, with no generics available.

“For the first time, we know that brand name drug retail prices are growing just as quickly as manufacturer prices,” said John Rother, AARP EVP, in a statement.

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.